Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012

11 May 2010 • by Natalie Aster

TechNavio Insights announces this week, the release of the report ‘Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012.’

Implantable Cardioverter Defibrillators (ICD) are surgically implanted in people to treat lethal ventricular arrhythmias, such as ventricular tachycardia or ventricular fibrillation.

Presently, ICDs are widely being used in Americas and Europe, and ICD therapies are growing potentially across Asian countries, such as China, Japan and India.

According to TechNavio, “the global market for ICD is estimated to grow 4.4% over the forecast period.”

The ICD delivers low-energy electric shocks to the heart, and restores the normal heart rhythm. Therefore, it is considered a primary therapeutic option for preventing sudden cardiac death due to its life saving benefits.

“Thanks to the advancement in new innovative technologies, companies are now launching ICDs to provide advanced rhythm management, addressing multiple types of rhythm disorders,’ says a TechNavio expert.

The report ‘Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012’, by TechNavio Insights highlights the scope of the ICD industry, as well as the forecasts the trends, drivers and challenges of this market.